Market Research Logo

Wockhardt Ltd (WOCKPHARMA) - Financial and Strategic SWOT Analysis Review

Wockhardt Ltd (WOCKPHARMA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes, among others. Wockhardt holds expertise in biotechnology research with a focus on gene cloning; and development of production strains and expression of proteins. It also concentrates its research in generics, novel drug delivery system; and new chemical entities. The company has presence in India, the UK, Switzerland and British Virgin Islands. Wockhardt is headquartered in Mumbai, Maharashtra, India.

Wockhardt Ltd Key Recent Developments

Jun 22,2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London
May 29,2017: WOCKPHARMA Announces Update on Aurangabad facility
May 04,2017: Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore
Mar 07,2017: WOCKPHARMA Provides Update on Aurangabad facility
Jan 24,2017: Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 cr

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Wockhardt Ltd - Key Facts 5
Wockhardt Ltd - Key Employees 6
Wockhardt Ltd - Key Employee Biographies 7
Wockhardt Ltd - Major Products and Services 8
Wockhardt Ltd - History 10
Wockhardt Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Wockhardt Ltd - Business Description 13
Wockhardt Ltd - SWOT Analysis 14
SWOT Analysis - Overview 14
Wockhardt Ltd - Strengths 14
Wockhardt Ltd - Weaknesses 15
Wockhardt Ltd - Opportunities 16
Wockhardt Ltd - Threats 17
Wockhardt Ltd - Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Wockhardt Ltd, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Jun 22, 2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London 29
May 29, 2017: WOCKPHARMA Announces Update on Aurangabad facility 30
May 04, 2017: Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore 31
Mar 07, 2017: WOCKPHARMA Provides Update on Aurangabad facility 33
Jan 24, 2017: Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 cr 34
Jan 05, 2017: Wockhardt Provides Update On Its Manufacturing Facility Ankaleshwar, Gujarat 35
Dec 19, 2016: Wockhardt Provides Update On Its Manufacturing Unit At Chikalthana, Aurangabad 36
Dec 13, 2016: Wockhardt Provides Update On Its Manufacturing Unit At Kadaiya, Daman 37
Nov 23, 2016: Wockhardt: USFDA Warning Letter to CP Pharmaceuticals 38
Nov 10, 2016: Wockhardt Q2FY17 Net Sales at Rs.1,065 crore, EBITDA at Rs. 100 crore, grew by 18% Quarter on Quarter 39
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
Wockhardt Ltd, Key Facts 5
Wockhardt Ltd, Key Employees 6
Wockhardt Ltd, Key Employee Biographies 7
Wockhardt Ltd, Major Products and Services 8
Wockhardt Ltd, History 10
Wockhardt Ltd, Other Locations 11
Wockhardt Ltd, Subsidiaries 11
Wockhardt Ltd, Key Competitors 18
Wockhardt Ltd, Ratios based on current share price 19
Wockhardt Ltd, Annual Ratios 20
Wockhardt Ltd, Annual Ratios (Cont...1) 21
Wockhardt Ltd, Annual Ratios (Cont...2) 22
Wockhardt Ltd, Interim Ratios 24
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Wockhardt Ltd, Recent Deals Summary 28
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44
List of Figures
Wockhardt Ltd, Performance Chart (2013 - 2017) 23
Wockhardt Ltd, Ratio Charts 25
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report